Copy HTML iframe code to your website:

Social Share

Term: GW Pharmaceuticals

  • Rate
GW Pharmaceuticals (Wikipedia)

GW Pharmaceuticals is a British pharmaceutics company known for its multiple sclerosis treatment product nabiximols (brand name, Sativex) which was the first natural cannabis plant derivative to gain market approval in any country. Another cannabis-based product, Epidiolex, was approved for treatment of epilepsy by the US Food and Drug Administration in 2018. It is a subsidiary of Jazz Pharmaceuticals.

GW Pharmaceuticals PLC
TypeSubsidiary
IndustryPharmaceutical industry
Founded1998; 24 years ago (1998)
FounderGeoffrey Guy
Brian Whittle
HeadquartersCambridge,
United Kingdom
Key people
Justin Gover (CEO)
ProductsEpidiolex (Epidyolex in Europe)
Nabiximols (Sativex)
RevenueIncrease $527 million (2020)
Decrease -$58 million (2020)
Total assetsIncrease $939 million (2020)
Total equityIncrease $741 million (2020)
Number of employees
1,161 (2020)
ParentJazz Pharmaceuticals
Websitewww.gwpharm.co.uk Edit this at Wikidata
Footnotes / references
Sale!
<< Go Back (Wiki Index)